The strong interaction between streptavidin (SA) and biotin is widely utilized in biotechnological applications. A SA variant, monovalent SA, was developed with a single and high affinity biotin-binding site within the intact tetramer. However, its structural characterization remains undetermined. Here, we seek to determine the crystal structure of monovalent SA at 1. Streptavidin (SA) is a tetrameric protein derived from the bacterium Streptomyces Avidini, which exhibits extraordinary affinity for biotin 1, 2 . The streptavidin-biotin system is acknowledged as one of the most stable noncovalent interactions and has wide applications in the field of biotechnology such as molecular-labeling, molecular-localization and targeted drug delivery 3, 4 . Recognizing the utility of this system in different applications, extensive engineering efforts have been made to modify the SA system. For example, to reduce the immunogenicity of SA in clinical use, a low immunogenic SA mutant has been designed and structurally investigated 5, 6 . Similarly, despite the high affinity of biotin-streptavidin, biotin dissociation results from low endosomal pH 7 or being attached to nanoparticles 8 . This issue was overcome by traptavidin, a SA variant bearing S52G/R53D mutants 9 , which was also explained later by its crystal structural 10 . Moreover, four biotin-binding sites of SA tetramer can multimerize biotinylated ligands, affecting their function or causing target aggregation 11 . Howarth et al. 12 reported the production of monovalent streptavidin with N23A/S27D/S45A triple mutants in three Dead subunits. This chimeric SA variant has a single biotin-binding site with high (femtomolar) affinity and is still in tetramer form. However, the information regarding the structural basis of its function is still missing.
wild-type SA subunit (WT subunit) from the other three inactive subunits (Dead subunits with N23A/S27D/ S45A triple mutations), the side chains at residue 23 and 27 of wild-type SA (PDB id: 3RY1) were removed and used for molecular replacement. After solving the phase, an unbiased map at reside 23 and 27 was subsequently generated to identify the missing side chain (Methods and Fig. 1b) . By this analysis, the chain A, B and C were identified as Dead subunits and chain D was identified as wild-type one (WT subunit). Notably, density around residue 45 was not included for this analysis because it locates to the L3,4 loop, which exhibited variable conformations.
Different conformations of L3,4 loop between wild type and Dead subunits. The biotin binding
sites are located at one end of these β -barrels (Fig. 1a) . L3,4 (residues 45-52) the loop connecting β -strands 3 and 4, exhibited different conformations among four subunits (Fig. 1a) . The L3,4 loop is usually flexible in apo-SA, adopting either 'open' or 'close' conformation while it always folds over bound biotin (in 'close' conformation) 10, 13 . To investigate the different conformations of L3,4 in monovalent SA, we then compared its four subunits with apo-SA open conformation (chain D of pdb id: 3RY1, referred as 'apo-open conformation' in later description), and biotin-bound 'close' conformation (chain A of pdb id: 1MK5, referred as 'biotin-close conformation' in later description). This revealed that WT subunit (chain D) resembles the biotin-close conformation while three Dead subunits (chain A, B and C) are comparable to the apo-open conformation ( Fig. 2 and Supplementary Table 1 ). The conformation of the L3,4 loop made the main difference between these two forms. This loop bends over the biotin site in the WT subunit (chain D). However, in all three Dead subunits (chain A, B and C), the L3,4 loops remain open, exposing their ligand binding sites (Fig. 3a) . Calculation of electron density near this loop region suggested the reliable tracing of main chain in four subunits, though the density was relatively weak in chain A (Fig. 3b) .
The 'open' L3,4 loops are consistently stabilized in all Dead streptavidin subunits. Loops between streptavidin β -strands are often involved in crystal packing 13 . We therefore evaluated the crystal packing around the L3,4 loop in monovalent SA structure. As a result, for the only WT subunit (chain D), there is only one H-bond between S52 main chain at the base of L3,4, and T66 main chain from L4,5 loop of neighboring subunit, which may favor the 'close' conformation of its L3,4 over 'open' conformation ( Supplementary Fig. 1d and e) . However, L3,4 loops within three Dead subunits (chain A, B and C) are free from crystal packing ( Supplementary  Fig. 1a-c) , which enabled us to evaluate direct effects of mutations on L3,4. As we discussed above, L3,4 of all three ( Fig. 4a-c) ; S52 main chain form a H-bond with S45A main chain. Notably, in previously reported wild-type apo-open conformation, we found similar H-bonding interactions within open L3,4, that is, S52 side chain forms H-bonds with N49 main chain and S45 main chain (Fig. 4e) . In contrast, in the close L3,4 observed in WT subunit (chain D), these interactions cannot be maintained because S52 rotates almost 180° (Fig. 4d) . These results in different SA variants indicated the important role of S52 in stabilizing the open conformation of L3,4.
In the WT subunit, one PEG molecule take up the space which biotin tail occupies and forms a H-bond with the N49 main chain, similar to biotin binding (Fig. 4d) . Therefore, the biotin-binding site of WT subunit closely resembles that observed in the biotin-bound state. Further superimposition of these different subunits revealed that S27D mutation may generate steric hindrance with A46 in close L3,4 (Fig. 4f) , suggesting this may result in the shift of this loop and form a preferred open conformation maintained by S52.
Discussion
By solving the structure of monovalent streptavidin, we found substantial conformational changes between the single wild-type subunit and three Dead subunits, localized to their L3,4 loops. Specifically, L3,4 loop folds over the biotin-binding site in WT subunit while it remains in 'open' conformation among three Dead subunits (Fig. 3a) . The L3,4 loops free from crystal packing (Supplementary Fig. 1 ) enabled us to evaluate the effects of N23A/S27D/S45A mutations on biotin binding (Fig. 4) . We found that S27D may sterically force the L3,4 to shift away from biotin-binding site and stabilize its open conformation through an H-bonding network involving S52 (Fig. 4f) . It was proposed that N23A/S27D/S45A directly attenuated the binding of biotin 12, 14 . Here our analysis suggest the stabilized open L3,4 caused by these mutants may further reduce the binding of biotin, because only close L3,4 can provide extra sites for biotin-binding (Fig. 4f) . Moreover, these stabilized open L3,4 loops may also expose the biotin binding site, resulting in fast release of biotin. Consistently, the open L3,4 was previously proposed to explain the fast dissociation of ALiS from SA 15 . All these effects together may account for the substantial reduction of biotin binding to N23A/S27D/S45A mutants 12 . Our results also suggested the important role of S52 in stabilizing the open conformation of L3,4, the 'lid' of the biotin-binding pocket. This involves H-bonds between S52, N49 and S45 (or A45 if mutated), which was observed in all three Dead subunits in this study, and also in apo-open wild-type SA (Fig. 4) . Previous studies indicated that SA S52G caused reduction of on-rate and off-rate binding constants for ligand binding, and SA structures having S52G mutants all exhibited closed L3,4 lid, regardless of the presence or absence of ligand 10, 16 . Based on our analysis, these effects of S52G are probably caused by the collapse of the H-bonding network within the open L3,4 and the subsequent destabilization of this open conformation. These insights emphasized the H-bonds within the open L3,4 loop in biotin-binding kinetics, which can be potential target for modulating SA properties to overcome its disadvantages such as non-favored ligand dissociation 7, 8 .
Materials and Methods
Monovalent streptavidin expression and purification. The monovalent streptavidin in tetrameric form was generated as previously described 12 . Briefly, wild-type SA (with His8-tag) and Dead (N23A/S27D/ S45A) SA (without His8-tag) were expressed in E. coli BL21 (DE3) cells as inclusion bodies. The collected cells were lysed by sonication and the inclusion bodies were isolated and washed twice with washing buffer (20 mM Tris-HCl, pH 8.0, 0.3 M NaCl, 2 M urea) to reach over 80% purity. The purified inclusion bodies pellet of wildtype and mutant streptavidin were both resuspended in solubilization buffer (20 mM Tris-HCl, pH 8.0, 0.3 M NaCl, 8 M urea) and then were centrifuged at 15,000 rpm for 30 min to remove insoluble material. After determining the concentration by OD280 (NanoDrop 2000, Thermo Scientific), the solubilized inclusion bodies of wild-type and mutated streptavidin were mixed in 1:3 ratio. The mixture was then fast diluted (drop by drop) into PBS buffer (10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 137 mM NaCl) for the refolding of streptavidin tetramer. Ammonium sulfated gradient precipitation was performed to remove the partially folded streptavidin and some contaminant protein 12, 17 . Different forms of the SA tetramer were separated through a step gradient elution on Nickel charged-nitrilotriacetic acid (Ni-NTA, Qiagen) affinity chromatography and monovalent streptavidin was eluted in buffer with 100 mM imidazole as previously described 18 . The sample was then incubated with the Proteinase K at the weight ration of 100:1 for 5hr at 20 °C to remove the only his-tag on wild-type SA subunit 18 . The protease-treated sample was further purified through size exclusion chromatography (Superdex 75 column) with Tris-sodium buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl) to remove the protease and to achieve more homogeneous state. The purified, tag-free monovalent SA tetramer was concentrated to 10-15 mg/ml and was frozen and stored at − 80 °C. Structural determination. Diffraction data was processed and scaled using Mosflm 19 . To solve the phase and to identify the only wild-type subunit, we used apo-SA tetramer (PDB id: 3RY1) as the search model with all the side chains at mutated sites 23, 27 being deleted. The molecular replacement was performed with MOLREP 20 (a program for automated molecular replacement where a homologous structure has already been identified) followed by one round of automatic refinement with REFMAC 21 in CCP4 19 . The fo-fc and 2fo-fc maps at this stage were then carefully analyzed to assign the wild-type and Dead subunits and to build the missing side chains. After that, several round of refinement with REFMAC (a program designed for REFinement of MACromolecular Scientific RepoRts | 6:35915 | DOI: 10.1038/srep35915 structures) and model adjustment with COOT 22 (Crystallographic Object-Oriented Toolkit) was performed. Waters were added to the models at the last stage. The statistics for data collection and refinement were summarized in Table 1 . Structural figures were made using a molecular graphics and modelling package (PyMOL) 23 . 
